| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Analysts' ratings for American Healthcare REIT (NYSE:AHR) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 5 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 2 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $41.83, a high estimate of $45.00, and a low estimate of $38.00. Marking an increase of 17.01%, the current average surpasses the previous average price target of $35.75.
A comprehensive examination of how financial experts perceive American Healthcare REIT is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Aaron Hecht | JMP Securities | Raises | Market Outperform | $45.00 | $40.00 |
| Wesley Golladay | Baird | Announces | Outperform | $41.00 | - |
| Nicholas Yulico | Scotiabank | Announces | Sector Outperform | $42.00 | - |
| Austin Wurschmidt | Keybanc | Raises | Overweight | $40.00 | $34.00 |
| Michael Lewis | Truist Securities | Raises | Buy | $38.00 | $32.00 |
| Ronald Kamdem | Morgan Stanley | Raises | Overweight | $45.00 | $37.00 |
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of American Healthcare REIT's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on American Healthcare REIT analyst ratings.
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: American Healthcare REIT's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 8.22%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: American Healthcare REIT's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -1.26%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): American Healthcare REIT's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -0.3%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): American Healthcare REIT's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.15%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.81.
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AHR
